| 85.77 Real-Time Quote |  +0.21 / +0.25%Today’s Change | 81.31 Today|||52-Week Range 101.18 | -7.58% Year-to-Date |
| Is IDEXX Laboratories a Fast Cash Machine? May 21 / MotleyFool.com | Why IDEXX Laboratories's Earnings Are Outstanding May 09 / MotleyFool.com |
| Don't Get Too Worked Up Over IDEXX Laboratories's Latest Numbers May 17 / MotleyFool.com |
| Previous close | 85.56 |
| Today’s open | 86.02 |
| Day’s range | 84.85 - 86.06 |
| Volume | 40,792 |
| Average volume (3 months) | 420,178 |
| Market cap | $4.6B |
| Dividend yield | -- |
| Earnings growth (last year) | +14.03% |
| Earnings growth (this year) | +9.83% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +6.13% |
| P/E ratio | 26.5 |
| Price/Sales | 3.95 |
| Price/Book | 7.33 |
| Today’s change | Today’s % change | |
|---|---|---|
| SGENSeattle Genetics Inc | +0.33 | +0.92% |
| ALKSAlkermes Plc | +0.67 | +2.10% |
| WCRXWarner Chilcott Plc | -0.32 | -1.55% |
| ENDPEndo Health Solution... | +0.23 | +0.68% |
| Next reporting date | July 26, 2013 |
| EPS forecast (this quarter) | $0.97 |
| Annual revenue (last year) | $1.3B |
| Annual profit (last year) | $178.3M |
| Net profit margin | 13.78% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Jonathan W. Ayers |
Chief Financial Officer & Vice President Willard R. Blanche, Jr. |
Corporate headquarters Westbrook, Maine |
.
